390 related articles for article (PubMed ID: 20687077)
1. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Williams K; Wheeler DM; Silove N; Hazell P
Cochrane Database Syst Rev; 2010 Aug; (8):CD004677. PubMed ID: 20687077
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Williams K; Brignell A; Randall M; Silove N; Hazell P
Cochrane Database Syst Rev; 2013 Aug; (8):CD004677. PubMed ID: 23959778
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769878
[TBL] [Abstract][Full Text] [Related]
5. Intravenous secretin for autism spectrum disorders (ASD).
Williams K; Wray JA; Wheeler DM
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003495. PubMed ID: 22513913
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
7. Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents.
Hurwitz R; Blackmore R; Hazell P; Williams K; Woolfenden S
Cochrane Database Syst Rev; 2012 Mar; (3):CD008372. PubMed ID: 22419332
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.
Kolevzon A; Mathewson KA; Hollander E
J Clin Psychiatry; 2006 Mar; 67(3):407-14. PubMed ID: 16649827
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Walitt B; Urrútia G; Nishishinya MB; Cantrell SE; Häuser W
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011735. PubMed ID: 26046493
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).
Soomro GM; Altman D; Rajagopal S; Oakley-Browne M
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD001765. PubMed ID: 18253995
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors for premenstrual syndrome.
Marjoribanks J; Brown J; O'Brien PM; Wyatt K
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
[TBL] [Abstract][Full Text] [Related]
13. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
Moore ML; Eichner SF; Jones JR
Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
[TBL] [Abstract][Full Text] [Related]
14. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
[TBL] [Abstract][Full Text] [Related]
16. Intravenous secretin for autism spectrum disorder.
Williams KW; Wray JJ; Wheeler DM
Cochrane Database Syst Rev; 2005 Jul; (3):CD003495. PubMed ID: 16034901
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine versus other types of pharmacotherapy for depression.
Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
20. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]